The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Type 1 Diabetes (T1D) Market Outlook 2025

Global Type 1 Diabetes (T1D) Market Outlook 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1633980

No of Pages : 111

Ask Your Query

Synopsis
Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person’s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body’s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.

Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D’s serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 50% of the total market share over the forecast period.

The global Type 1 Diabetes (T1D) market was valued at US$ 1901.2 million in 2020 and is expected to reach US$ 2685.2 million by the end of 2027, growing at a CAGR of 4.6% during 2021-2027.

This report focuses on Type 1 Diabetes (T1D) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Type 1 Diabetes (T1D) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Type 1 Diabetes (T1D) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Rapid Acting Insulin Analogs
  • Long Acting Insulin Analogs
  • Premix Insulin Analogs

Segment by Application

  • Children
  • Adults

By Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Novo Nordisk
  • Sanofi
  • Eli Lilly
  • Merck
  • Boehringer Ingelheim
  • Samsung Bioepis
  • Biocon
  • Astellas
  • Janssen
  • Bristol-Myers Squibb
  • Lexicon
  • Sanofi

Scope of the Type 1 Diabetes (T1D) Market Report

Report Metric

Details

Report Name

Type 1 Diabetes (T1D) Market

Market size in 2020

US$ 1901.2 Million

The revenue forecast in 2027

US$ 2685.2 Million

Growth Rate

CAGR of 4.6% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Type 1 Diabetes (T1D) Market Overview
1.1 Product Overview and Scope of Type 1 Diabetes (T1D)
1.2 Type 1 Diabetes (T1D) Segment by Type
1.2.1 Global Type 1 Diabetes (T1D) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Rapid Acting Insulin Analogs
1.2.3 Long Acting Insulin Analogs
1.2.4 Premix Insulin Analogs
1.3 Type 1 Diabetes (T1D) Segment by Application
1.3.1 Global Type 1 Diabetes (T1D) Sales Comparison by Application: (2021-2027)
1.3.2 Children
1.3.3 Adults
1.4 Global Type 1 Diabetes (T1D) Market Size Estimates and Forecasts
1.4.1 Global Type 1 Diabetes (T1D) Revenue 2016-2027
1.4.2 Global Type 1 Diabetes (T1D) Sales 2016-2027
1.4.3 Type 1 Diabetes (T1D) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Type 1 Diabetes (T1D) Market Competition by Manufacturers
2.1 Global Type 1 Diabetes (T1D) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Type 1 Diabetes (T1D) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Type 1 Diabetes (T1D) Manufacturing Sites, Area Served, Product Type
2.5 Type 1 Diabetes (T1D) Market Competitive Situation and Trends
2.5.1 Type 1 Diabetes (T1D) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Type 1 Diabetes (T1D) Players Market Share by Revenue
2.5.3 Global Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Type 1 Diabetes (T1D) Retrospective Market Scenario by Region
3.1 Global Type 1 Diabetes (T1D) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Type 1 Diabetes (T1D) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Type 1 Diabetes (T1D) Market Facts & Figures by Country
3.3.1 North America Type 1 Diabetes (T1D) Sales by Country
3.3.2 North America Type 1 Diabetes (T1D) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Type 1 Diabetes (T1D) Market Facts & Figures by Country
3.4.1 Europe Type 1 Diabetes (T1D) Sales by Country
3.4.2 Europe Type 1 Diabetes (T1D) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Type 1 Diabetes (T1D) Market Facts & Figures by Region
3.5.1 Asia Pacific Type 1 Diabetes (T1D) Sales by Region
3.5.2 Asia Pacific Type 1 Diabetes (T1D) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Type 1 Diabetes (T1D) Market Facts & Figures by Country
3.6.1 Latin America Type 1 Diabetes (T1D) Sales by Country
3.6.2 Latin America Type 1 Diabetes (T1D) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Type 1 Diabetes (T1D) Market Facts & Figures by Country
3.7.1 Middle East and Africa Type 1 Diabetes (T1D) Sales by Country
3.7.2 Middle East and Africa Type 1 Diabetes (T1D) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Type 1 Diabetes (T1D) Historic Market Analysis by Type
4.1 Global Type 1 Diabetes (T1D) Sales Market Share by Type (2016-2021)
4.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2016-2021)
4.3 Global Type 1 Diabetes (T1D) Price by Type (2016-2021)

5 Global Type 1 Diabetes (T1D) Historic Market Analysis by Application
5.1 Global Type 1 Diabetes (T1D) Sales Market Share by Application (2016-2021)
5.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2016-2021)
5.3 Global Type 1 Diabetes (T1D) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Eli Lilly Type 1 Diabetes (T1D) Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Type 1 Diabetes (T1D) Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Samsung Bioepis
6.6.1 Samsung Bioepis Corporation Information
6.6.2 Samsung Bioepis Description and Business Overview
6.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio
6.6.5 Samsung Bioepis Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biocon Type 1 Diabetes (T1D) Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Astellas
6.8.1 Astellas Corporation Information
6.8.2 Astellas Description and Business Overview
6.8.3 Astellas Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Astellas Type 1 Diabetes (T1D) Product Portfolio
6.8.5 Astellas Recent Developments/Updates
6.9 Janssen
6.9.1 Janssen Corporation Information
6.9.2 Janssen Description and Business Overview
6.9.3 Janssen Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Janssen Type 1 Diabetes (T1D) Product Portfolio
6.9.5 Janssen Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 Lexicon
6.11.1 Lexicon Corporation Information
6.11.2 Lexicon Type 1 Diabetes (T1D) Description and Business Overview
6.11.3 Lexicon Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Lexicon Type 1 Diabetes (T1D) Product Portfolio
6.11.5 Lexicon Recent Developments/Updates
6.12 Sanofi
6.12.1 Sanofi Corporation Information
6.12.2 Sanofi Type 1 Diabetes (T1D) Description and Business Overview
6.12.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
6.12.5 Sanofi Recent Developments/Updates

7 Type 1 Diabetes (T1D) Manufacturing Cost Analysis
7.1 Type 1 Diabetes (T1D) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Type 1 Diabetes (T1D)
7.4 Type 1 Diabetes (T1D) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Type 1 Diabetes (T1D) Distributors List
8.3 Type 1 Diabetes (T1D) Customers

9 Type 1 Diabetes (T1D) Market Dynamics
9.1 Type 1 Diabetes (T1D) Industry Trends
9.2 Type 1 Diabetes (T1D) Growth Drivers
9.3 Type 1 Diabetes (T1D) Market Challenges
9.4 Type 1 Diabetes (T1D) Market Restraints

10 Global Market Forecast
10.1 Type 1 Diabetes (T1D) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Type 1 Diabetes (T1D) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Type 1 Diabetes (T1D) by Type (2022-2027)
10.2 Type 1 Diabetes (T1D) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Type 1 Diabetes (T1D) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Type 1 Diabetes (T1D) by Application (2022-2027)
10.3 Type 1 Diabetes (T1D) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Type 1 Diabetes (T1D) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Type 1 Diabetes (T1D) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Type 1 Diabetes (T1D) Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Type 1 Diabetes (T1D) Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Type 1 Diabetes (T1D) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Type 1 Diabetes (T1D) Covered in This Study
Table 5. Global Type 1 Diabetes (T1D) Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Type 1 Diabetes (T1D) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Type 1 Diabetes (T1D) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Type 1 Diabetes (T1D) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Type 1 Diabetes (T1D) Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Type 1 Diabetes (T1D) Manufacturing Sites and Area Served
Table 11. Manufacturers Type 1 Diabetes (T1D) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Type 1 Diabetes (T1D) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 1 Diabetes (T1D) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Type 1 Diabetes (T1D) Sales by Region (2016-2021) & (K MT)
Table 16. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2016-2021)
Table 17. Global Type 1 Diabetes (T1D) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Type 1 Diabetes (T1D) Sales by Country (2016-2021) & (K MT)
Table 19. North America Type 1 Diabetes (T1D) Sales Market Share by Country (2016-2021)
Table 20. North America Type 1 Diabetes (T1D) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Type 1 Diabetes (T1D) Revenue Market Share by Country (2016-2021)
Table 22. Europe Type 1 Diabetes (T1D) Sales by Country (2016-2021) & (K MT)
Table 23. Europe Type 1 Diabetes (T1D) Sales Market Share by Country (2016-2021)
Table 24. Europe Type 1 Diabetes (T1D) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Type 1 Diabetes (T1D) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Type 1 Diabetes (T1D) Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Type 1 Diabetes (T1D) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Type 1 Diabetes (T1D) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Type 1 Diabetes (T1D) Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Type 1 Diabetes (T1D) Sales Market Share by Country (2016-2021)
Table 32. Latin America Type 1 Diabetes (T1D) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Type 1 Diabetes (T1D) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Type 1 Diabetes (T1D) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Type 1 Diabetes (T1D) Revenue Market Share by Country (2016-2021)
Table 38. Global Type 1 Diabetes (T1D) Sales (K MT) by Type (2016-2021)
Table 39. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2016-2021)
Table 40. Global Type 1 Diabetes (T1D) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Type 1 Diabetes (T1D) Revenue Share by Type (2016-2021)
Table 42. Global Type 1 Diabetes (T1D) Price (USD/MT) by Type (2016-2021)
Table 43. Global Type 1 Diabetes (T1D) Sales (K MT) by Application (2016-2021)
Table 44. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2016-2021)
Table 45. Global Type 1 Diabetes (T1D) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Type 1 Diabetes (T1D) Revenue Share by Application (2016-2021)
Table 47. Global Type 1 Diabetes (T1D) Price (USD/MT) by Application (2016-2021)
Table 48. Novo Nordisk Corporation Information
Table 49. Novo Nordisk Description and Business Overview
Table 50. Novo Nordisk Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Novo Nordisk Type 1 Diabetes (T1D) Product
Table 52. Novo Nordisk Recent Developments/Updates
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Sanofi Type 1 Diabetes (T1D) Product
Table 57. Sanofi Recent Developments/Updates
Table 58. Eli Lilly Corporation Information
Table 59. Eli Lilly Description and Business Overview
Table 60. Eli Lilly Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Eli Lilly Type 1 Diabetes (T1D) Product
Table 62. Eli Lilly Recent Developments/Updates
Table 63. Merck Corporation Information
Table 64. Merck Description and Business Overview
Table 65. Merck Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Merck Type 1 Diabetes (T1D) Product
Table 67. Merck Recent Developments/Updates
Table 68. Boehringer Ingelheim Corporation Information
Table 69. Boehringer Ingelheim Description and Business Overview
Table 70. Boehringer Ingelheim Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Boehringer Ingelheim Type 1 Diabetes (T1D) Product
Table 72. Boehringer Ingelheim Recent Developments/Updates
Table 73. Samsung Bioepis Corporation Information
Table 74. Samsung Bioepis Description and Business Overview
Table 75. Samsung Bioepis Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Samsung Bioepis Type 1 Diabetes (T1D) Product
Table 77. Samsung Bioepis Recent Developments/Updates
Table 78. Biocon Corporation Information
Table 79. Biocon Description and Business Overview
Table 80. Biocon Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Biocon Type 1 Diabetes (T1D) Product
Table 82. Biocon Recent Developments/Updates
Table 83. Astellas Corporation Information
Table 84. Astellas Description and Business Overview
Table 85. Astellas Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Astellas Type 1 Diabetes (T1D) Product
Table 87. Astellas Recent Developments/Updates
Table 88. Janssen Corporation Information
Table 89. Janssen Description and Business Overview
Table 90. Janssen Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Janssen Type 1 Diabetes (T1D) Product
Table 92. Janssen Recent Developments/Updates
Table 93. Bristol-Myers Squibb Corporation Information
Table 94. Bristol-Myers Squibb Description and Business Overview
Table 95. Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Bristol-Myers Squibb Type 1 Diabetes (T1D) Product
Table 97. Bristol-Myers Squibb Recent Developments/Updates
Table 98. Lexicon Corporation Information
Table 99. Lexicon Description and Business Overview
Table 100. Lexicon Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Lexicon Type 1 Diabetes (T1D) Product
Table 102. Lexicon Recent Developments/Updates
Table 103. Sanofi Corporation Information
Table 104. Sanofi Description and Business Overview
Table 105. Sanofi Type 1 Diabetes (T1D) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Sanofi Type 1 Diabetes (T1D) Product
Table 107. Sanofi Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Type 1 Diabetes (T1D) Distributors List
Table 111. Type 1 Diabetes (T1D) Customers List
Table 112. Type 1 Diabetes (T1D) Market Trends
Table 113. Type 1 Diabetes (T1D) Growth Drivers
Table 114. Type 1 Diabetes (T1D) Market Challenges
Table 115. Type 1 Diabetes (T1D) Market Restraints
Table 116. Global Type 1 Diabetes (T1D) Sales Forecast by Type (2022-2027) & (K MT)
Table 117. Global Type 1 Diabetes (T1D) Sales Market Share Forecast by Type (2022-2027)
Table 118. Global Type 1 Diabetes (T1D) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 119. Global Type 1 Diabetes (T1D) Revenue Market Share Forecast by Type (2022-2027)
Table 120. Global Type 1 Diabetes (T1D) Sales Forecast by Application (2022-2027) & (K MT)
Table 121. Global Type 1 Diabetes (T1D) Sales Market Share Forecast by Application (2022-2027)
Table 122. Global Type 1 Diabetes (T1D) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 123. Global Type 1 Diabetes (T1D) Revenue Market Share Forecast by Application (2022-2027)
Table 124. Global Type 1 Diabetes (T1D) Sales Forecast by Region (2022-2027) & (K MT)
Table 125. Global Type 1 Diabetes (T1D) Sales Market Share Forecast by Region (2022-2027)
Table 126. Global Type 1 Diabetes (T1D) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 127. Global Type 1 Diabetes (T1D) Revenue Market Share Forecast by Region (2022-2027)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Type 1 Diabetes (T1D)
Figure 2. Global Type 1 Diabetes (T1D) Market Share by Type in 2020 & 2027
Figure 3. Rapid Acting Insulin Analogs Product Picture
Figure 4. Long Acting Insulin Analogs Product Picture
Figure 5. Premix Insulin Analogs Product Picture
Figure 6. Global Type 1 Diabetes (T1D) Market Share by Application in 2020 & 2027
Figure 7. Children
Figure 8. Adults
Figure 9. Global Type 1 Diabetes (T1D) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Type 1 Diabetes (T1D) Market Size 2016-2027 (US$ Million)
Figure 11. Global Type 1 Diabetes (T1D) Sales 2016-2027 (K MT)
Figure 12. Global Type 1 Diabetes (T1D) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Type 1 Diabetes (T1D) Sales Share by Manufacturers in 2020
Figure 14. Global Type 1 Diabetes (T1D) Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Type 1 Diabetes (T1D) Players: Market Share by Revenue in 2020
Figure 16. Type 1 Diabetes (T1D) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2016-2021)
Figure 18. Global Type 1 Diabetes (T1D) Sales Market Share by Region in 2020
Figure 19. Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2016-2021)
Figure 20. Global Type 1 Diabetes (T1D) Revenue Market Share by Region in 2020
Figure 21. U.S. Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Type 1 Diabetes (T1D) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Type 1 Diabetes (T1D) by Type (2016-2021)
Figure 46. Sales Market Share of Type 1 Diabetes (T1D) by Application (2016-2021)
Figure 47. Sales Market Share of Type 1 Diabetes (T1D) by Application in 2020
Figure 48. Revenue Share of Type 1 Diabetes (T1D) by Application (2016-2021)
Figure 49. Revenue Share of Type 1 Diabetes (T1D) by Application in 2020
Figure 50. Manufacturing Cost Structure of Type 1 Diabetes (T1D)
Figure 51. Manufacturing Process Analysis of Type 1 Diabetes (T1D)
Figure 52. Type 1 Diabetes (T1D) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock